The FDA determined that the 3-dose Pfizer COVID-19 vaccine worked in children aged 6 months through 4 years; the bipartisan Senate gun deal will focuses on mental health; the pandemic has other viruses acting mysteriously, with children diagnosed with respiratory viruses in May and June.
The 3-dose COVID-19 vaccine from Pfizer and BioNTech was found to have worked in young children aged 6 months to 4 years, according to The Wall Street Journal. The FDA also found that the data proved that there were no new safety concerns with using the vaccine in young children compared with the rest of the population. This announcement comes mere days from when an FDA staff review found that the Moderna vaccine was also safe for young children of the same age group. These findings could indicate that the vaccine will be made available to this age group soon, with the Biden administration saying that vaccinations for young children could be made available by June 21.
A bipartisan gun deal from Senators Debbie Stabenow (D-Mich.) and Roy Blunt (R-Mo.) would include funding for community mental health clinics nationwide that would provide mental health crisis response, substance abuse treatment, and other services around the clock, according to The Hill. The measure would expand the mental health clinic program, which currently only has 10 states fully participating. The framework released by the 20 senators who are working on the bill called for “major investments to increase access to mental health and suicide prevention programs” although no hard figure was provided.
Viruses which are typically limited to the winter months, including respiratory syncytial virus and the flu, are becoming more common in the summer months, according to The Washington Post. Due to this increase in virus cases outside of their usual season, doctors are thinking of keeping more vaccinesn on hand in the spring and summer. Epidemiologists are also looking into what stay-at-home orders, masking, and social distancing may have done to affect virus cases thereafter. Researchers and doctors suggest that the removal of masks and gatherings held indoors when population immunity was low may have been the cause of the increase in out-of-season virus cases.
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Increased Interest in Advance Provision and Over-the-Counter Medication Abortion
January 16th 2025An increased public interest and support for medication abortion following the federal Supreme Court ruling, particularly among marginalized groups, suggests a shift towards more accessible and autonomous models of abortion care.
Read More